Milkie Vu1, Victoria N Huynh2, Carla J Berg3, Caitlin G Allen4, Phuong-Linh H Nguyen5, Ngoc-Anh Tran6, Yotin Srivanjarean7, Cam Escoffery4. 1. Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA. milkie.vu@emory.edu. 2. Emory College of Arts & Sciences, Emory University, Atlanta, GA, USA. 3. Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, D.C, USA. 4. Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA. 5. Hanoi-Amsterdam High School for the Gifted, Hanoi, Vietnam. 6. Nguyen Hue High School for the Gifted, Hanoi, Vietnam. 7. Center for Pan Asian Community Services, Atlanta, GA, USA.
Abstract
BACKGROUND: Compared to other racial/ethnic groups, U.S. Vietnamese have higher Hepatitis B infection prevalence, which is a major liver cancer risk factor. Increased testing could reduce this disparity. It is critical to understand subgroups of U.S. Vietnamese least likely to have been tested for Hepatitis B and design appropriate interventions. We examined healthcare- and acculturation-related factors influencing Hepatitis B testing among U.S. Vietnamese. METHODS: Survey data of 100 U.S. Vietnamese attending health fairs/programs hosted by community-based organizations (2017-2018) were analyzed. Healthcare-related predictors included insurance and past 2-year checkup. Acculturation-related predictors included Vancouver Acculturation Index, percentage of lifetime in the U.S., and Vietnamese and English fluency. We conducted a multiple logistic regression controlling for age, sex, education, and household income. RESULTS: The sample was an average 37.5 years old and 61.6% female. Insurance coverage was reported by 83.0%. Average percentage of lifetime in the U.S. was 56.8%. Seventy percent reported having received Hepatitis B testing. Hepatitis B testing was associated with health insurance (aOR = 2.61, 95% CI = [1.05-6.47], p = .04) but not any acculturation-related predictors CONCLUSION: Improving insurance coverage and options can be a strategy to increase Hepatitis B testing among U.S. Vietnamese. More education regarding Hepatitis B (e.g., via community-based, culturally-appropriate, lay health worker-led programs) is needed to ensure that individuals are aware of their testing status and pursue appropriate healthcare decisions.
BACKGROUND: Compared to other racial/ethnic groups, U.S. Vietnamese have higher Hepatitis B infection prevalence, which is a major liver cancer risk factor. Increased testing could reduce this disparity. It is critical to understand subgroups of U.S. Vietnamese least likely to have been tested for Hepatitis B and design appropriate interventions. We examined healthcare- and acculturation-related factors influencing Hepatitis B testing among U.S. Vietnamese. METHODS: Survey data of 100 U.S. Vietnamese attending health fairs/programs hosted by community-based organizations (2017-2018) were analyzed. Healthcare-related predictors included insurance and past 2-year checkup. Acculturation-related predictors included Vancouver Acculturation Index, percentage of lifetime in the U.S., and Vietnamese and English fluency. We conducted a multiple logistic regression controlling for age, sex, education, and household income. RESULTS: The sample was an average 37.5 years old and 61.6% female. Insurance coverage was reported by 83.0%. Average percentage of lifetime in the U.S. was 56.8%. Seventy percent reported having received Hepatitis B testing. Hepatitis B testing was associated with health insurance (aOR = 2.61, 95% CI = [1.05-6.47], p = .04) but not any acculturation-related predictors CONCLUSION: Improving insurance coverage and options can be a strategy to increase Hepatitis B testing among U.S. Vietnamese. More education regarding Hepatitis B (e.g., via community-based, culturally-appropriate, lay health worker-led programs) is needed to ensure that individuals are aware of their testing status and pursue appropriate healthcare decisions.
Authors: J B Kallman; S Tran; A Arsalla; D Haddad; M Stepanova; Y Fang; V J Wrobel; M Srishord; Z M Younossi Journal: J Viral Hepat Date: 2011-01 Impact factor: 3.728
Authors: Scott P Grytdal; Youlian Liao; Roxana Chen; Cheza C Garvin; Dorcas Grigg-Saito; Marjorie Kagawa-Singer; Sidney Liang; Stephen J McPhee; Tung T Nguyen; Jacqueline H Tran; Kathleen M Gallagher Journal: J Community Health Date: 2009-06
Authors: Annette E Maxwell; Roshan Bastani; Beth A Glenn; Victoria M Taylor; Tung T Nguyen; Susan L Stewart; Nancy J Burke; Moon S Chen Journal: Prev Chronic Dis Date: 2014-05-01 Impact factor: 2.830